Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Lipidor

Mindre end 1K følgere
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse25.5.2025, 15.25

Lipidor applies for bankruptcy

Lipidor
Selskabsmeddelelse24.5.2025, 10.40

Lipidor announces today negative results from the company's Phase III clinical study of AKP02G2 for psoriasis

Lipidor
Pressemeddelelse19.5.2025, 06.30

Lipidor announces database lock in its Phase III clinical study of the psoriasis candidate AKP02G2

Lipidor

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse9.5.2025, 12.25

Lipidor AB (publ) publishes annual report for 2024

Lipidor
Pressemeddelelse17.3.2025, 07.30

Lipidor announces all patients enrolled in ongoing Phase III study

Lipidor
Selskabsmeddelelse28.2.2025, 07.30

Lipidor AB (publ) publishes year-end report for 2024

Lipidor
Pressemeddelelse21.1.2025, 07.00

Lipidor announces half of patients enrolled in ongoing Phase III study

Lipidor
Selskabsmeddelelse3.12.2024, 07.00

Lipidor presents Nomination Committee

Lipidor
Pressemeddelelse20.11.2024, 07.00

Lipidor publishes CEO statement for the quarter: "Study results expected by the end of Q1 2025"

Lipidor
Pressemeddelelse24.9.2024, 16.30

Lipidor announces first patient enrolled in Phase III study of AKP02G2 for topical treatment of psoriasis

Lipidor
Selskabsmeddelelse28.8.2024, 06.30

Lipidor AB (publ) publishes interim report for Q2 2024

Lipidor
Pressemeddelelse20.8.2024, 11.50

Lipidor announces that clinical trial material for psoriasis candidate AKP02G2 has been released according to plan

Lipidor
Selskabsmeddelelse1.7.2024, 06.15

Lipidor resolves on a directed issue of shares to underwriters in connection with the completion of the rights issue

Lipidor
Selskabsmeddelelse25.6.2024, 19.57

Lipidor's rights issue and share capital reduction are registered – conversion of BTU into shares and warrants

Lipidor
Selskabsmeddelelse13.6.2024, 18.46

Lipidor announces final outcome in the rights issue

Lipidor
Selskabsmeddelelse12.6.2024, 18.58

Lipidor announces preliminary outcome in the rights issue

Lipidor
Selskabsmeddelelse7.6.2024, 06.30

Last day of trading in unit rights in Lipidor's rights issue

Lipidor
Selskabsmeddelelse5.6.2024, 08.00

Bulletin from the Annual General Meeting of Lipidor AB (publ)

Lipidor
Selskabsmeddelelse29.5.2024, 06.30

Lipidor invites to digital presentations with Q&A

Lipidor
Selskabsmeddelelse29.5.2024, 06.00

Today the subscription period in Lipidor's rights issue begins

Lipidor
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.